Lumiracoxib
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Osteoarthritis With Controlled Hypertension
Conditions
Osteoarthritis With Controlled Hypertension
Trial Timeline
Nov 1, 2006 → Sep 1, 2007
NCT ID
NCT00419796About Lumiracoxib
Lumiracoxib is a approved stage product being developed by Novartis for Osteoarthritis With Controlled Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT00419796. Target conditions include Osteoarthritis With Controlled Hypertension.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (14)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00419796 | Approved | Completed |
| NCT00333567 | Approved | Completed |
| NCT00350155 | Approved | Completed |
| NCT00348491 | Approved | Completed |
| NCT00267176 | Approved | Completed |
| NCT00170781 | Approved | Completed |
| NCT00170898 | Approved | Completed |
| NCT00170872 | Phase 3 | Completed |
| NCT00145301 | Phase 3 | Completed |
| NCT00475800 | Phase 3 | Completed |
| NCT00476034 | Phase 3 | Completed |
| NCT00366938 | Phase 3 | Completed |
| NCT00367315 | Phase 3 | Completed |
| NCT00267215 | Phase 3 | Completed |
Competing Products
20 competing products in Osteoarthritis With Controlled Hypertension